Suture Licellvi package [Photo = Hugel]
It was announced on the 9th that Hugel's PDO suture brand 'Licellvi (domestic product name: Blue Rose Forte)' has obtained product approval from the Brazilian Food and Drug Administration (ANVISA).
---
With the approval of Licellvi, Hugel has achieved the success of entering the suture market in the Brazilian market following the botulinum toxin product 'Letybo' (domestic product name: Botulax).
Brazil is the largest market in Central and South America and the world's third largest aesthetic market as a single country. According to Verified Market Research, a global market research company, the size of the Brazilian thread lifting market is expected to grow at an average annual rate of 7.91% and reach approximately KRW 255.7 billion in 2030.
Hugel plans to establish a differentiated marketing strategy tailored to local characteristics with the goal of quickly establishing itself in the market. Since Brazil has the unique characteristic of conducting separate brands for plastic surgery, dermatology, and dentistry, the plan is to vary sales and sales activities for each department to reflect this.
A Hugel official said, “We plan to establish a systematic market entry strategy so that products containing Hugel’s technology, including PDO sutures, can quickly settle in the market.”
Copyright © Medi Consumer News Unauthorized reproduction and redistribution prohibited
(http://www.medisobizanews.com)
Suture Licellvi package [Photo = Hugel]
It was announced on the 9th that Hugel's PDO suture brand 'Licellvi (domestic product name: Blue Rose Forte)' has obtained product approval from the Brazilian Food and Drug Administration (ANVISA).
---
With the approval of Licellvi, Hugel has achieved the success of entering the suture market in the Brazilian market following the botulinum toxin product 'Letybo' (domestic product name: Botulax).
Brazil is the largest market in Central and South America and the world's third largest aesthetic market as a single country. According to Verified Market Research, a global market research company, the size of the Brazilian thread lifting market is expected to grow at an average annual rate of 7.91% and reach approximately KRW 255.7 billion in 2030.
Hugel plans to establish a differentiated marketing strategy tailored to local characteristics with the goal of quickly establishing itself in the market. Since Brazil has the unique characteristic of conducting separate brands for plastic surgery, dermatology, and dentistry, the plan is to vary sales and sales activities for each department to reflect this.
A Hugel official said, “We plan to establish a systematic market entry strategy so that products containing Hugel’s technology, including PDO sutures, can quickly settle in the market.”
Copyright © Medi Consumer News Unauthorized reproduction and redistribution prohibited
(http://www.medisobizanews.com)